Comparison of Psychological and Pharmacological Treatments for Pain Due to Temporomandibular Joint Disorder (TMD)

PHASE2CompletedINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

November 30, 2002

Primary Completion Date

June 30, 2008

Study Completion Date

July 31, 2008

Conditions
Temporomandibular Joint Disorders
Interventions
DRUG

Nortriptyline Oral Capsule

Nortriptyline will be titrated up from 25 mg qhs to a maximum dose of 150 mg qhs based on treatment response and side effect profile.

DRUG

Benztropine Oral Product

Benztropine will be titrated up from .125 mg qhs to a maximum dose of .750 mg qhs based on treatment response and side effect profile.

BEHAVIORAL

CBT

Six in-person, individual sessions of cognitive-behavioral therapy for pain management include relaxation training, pain coping skills training, cognitive therapy for negative and dysfunctional thoughts, and diaries for monitoring relaxation, goals, and negative thinking.

BEHAVIORAL

Disease MGT

Six in-person, individual sessions of temporomandibular joint disorder (TMD) disease management (MGT) that include information about the jaw and good oral habits, diet, sleep, and general stress management.

Trial Locations (1)

21201

University of Maryland, Dental School, Baltimore

All Listed Sponsors
collaborator

National Institute of Dental and Craniofacial Research (NIDCR)

NIH

lead

Johns Hopkins University

OTHER

NCT00066937 - Comparison of Psychological and Pharmacological Treatments for Pain Due to Temporomandibular Joint Disorder (TMD) | Biotech Hunter | Biotech Hunter